Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker INTS
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 5, 2026 | INTS Intensity Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 11, 2026 | INTS Intensity Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 16, 2026 | INTS Intensity Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 7, 2026 | INTS Intensity Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 27, 2026 | INTS Intensity Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 23, 2026 | INTS Intensity Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 6, 2026 | INTS Intensity Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 5, 2026 | INTS Intensity Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 13, 2026 | INTS Intensity Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 13, 2026 | INTS Intensity Therapeutics, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Feb 13, 2026 | INTS Intensity Therapeutics, Inc. | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
| Dec 5, 2025 | INTS Intensity Therapeutics, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Dec 4, 2025 | INTS Intensity Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 6, 2025 | INTS Intensity Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 31, 2025 | INTS Intensity Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 31, 2025 | INTS Intensity Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 23, 2025 | INTS Intensity Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Sep 10, 2025 | INTS Intensity Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 12, 2025 | INTS Intensity Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 12, 2025 | INTS Intensity Therapeutics, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Aug 7, 2025 | INTS Intensity Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 4, 2025 | INTS Intensity Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 18, 2025 | INTS Intensity Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 13, 2025 | INTS Intensity Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 13, 2025 | INTS Intensity Therapeutics, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jun 13, 2025 | INTS Intensity Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 6, 2025 | INTS Intensity Therapeutics, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| May 20, 2025 | INTS Intensity Therapeutics, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| May 13, 2025 | INTS Intensity Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 25, 2025 | INTS Intensity Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Apr 25, 2025 | INTS Intensity Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Apr 23, 2025 | INTS Intensity Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 13, 2025 | INTS Intensity Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 22, 2024 | INTS Intensity Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 22, 2024 | INTS Intensity Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 13, 2024 | INTS Intensity Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 23, 2024 | INTS Intensity Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
37 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:52 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances